Skip to main content
An official website of the United States government
Government Funding Lapse
Because of a lapse in government funding, the information on this website may not be up to date, transactions submitted via the website may not be processed, and the agency may not be able to respond to inquiries until appropriations are enacted.

The NIH Clinical Center (the research hospital of NIH) is open. For more details about its operating status, please visit cc.nih.gov.

Updates regarding government operating status and resumption of normal operations can be found at opm.gov.

tretinoin

A naturally-occurring acid of retinol. Tretinoin binds to and activates retinoic acid receptors (RARs), thereby inducing changes in gene expression that lead to cell differentiation, decreased cell proliferation, and inhibition of tumorigenesis. This agent also inhibits telomerase, resulting in telomere shortening and eventual apoptosis of some tumor cell types. The oral form of tretinoin has teratogenic and embryotoxic properties.
Check for active clinical trials using this agentView this agent in the NCI Thesaurus
Synonym:all-trans retinoic acid
all-trans vitamin A acid
beta-retinoic acid
retinoic acid
TRA
trans retinoic acid
trans vitamin A acid
tretinoinum
Vitamin A Acid
US brand name:Aberel
Aknoten
Avita
Renova
Retin-A
Retin-A MICRO
Vesanoid
Foreign brand name:Airol
Cordes Vas
Dermairol
Epi-Aberel
Eudyna
Retisol-A
Stieva-A
Stieva-A Forte
Vitinoin
Abbreviation:ATRA
Acronym:ATRA
TRA
Code name:Ro 5488
Chemical structure:(All-E)-3,7-dimethyl-9-(2,6,6-trimethyl-1-cyclohexen-1-yl)-2,4,6,8-nonatetraenoic acid
IND number:34987
NSC code:122758
Search NCI's Drug Dictionary
Please enter up to 30 characters for your search